Sunday, December 22, 2024
type here...
- Advertisement -spot_img

TAG

Wockhardt insulin

Business

Wockhardt files new fast-acting insulin with DCGI, shares surge

whatnews.in -
Wockhardt Limited, the global pharmaceutical company, has submitted its indigenously developed fast-acting insulin analog, ASPARAPID, for regulatory approval with India’s Drugs Controller General...

Latest news

- Advertisement -spot_img

© whatnews. All rights reserved.

About Us

WhatNews is your one-stop shop for financial news. From global markets to personal finance tips, we've got you covered.